- Illumina’s Bid to Beat Cancer with DNA Tests
The DNA sequencing giant will launch a new company, Grail, to develop blood tests to detect cancer.
- Hope in a Glove for Parkinson’s Patients
A wearable device promises to help steady hand tremors by using an old technology—gyroscopes.
- Parents Turn to Prozac to Treat Down Syndrome
The disorder known as trisomy 21 is untreatable. Or is it? Some families think an antidepressant could help.
- Big Pharma Doubles Down on CRISPR for New Drugs
A joint venture between Bayer and CRISPR Therapeutics is the latest effort to make CRISPR drugs that could target and modify cells inside the body.
- RIP David Bowie, Internet Pioneer
Long before MySpace, the late rock star was focused on connecting with his fans online.
- In Pursuit of an Affordable Tablet for the Blind
By borrowing from microfluidics, a team of University of Michigan researchers are reinventing the Braille display to be cheaper and more useful.
- Advanced Nuclear Startup Terrestrial Energy Lands Initial Funding
Canadian startup pursuing an advanced molten-salt nuclear reactor gets significant outside backing. <
This new data poisoning tool lets artists fight back against generative AI
The tool, called Nightshade, messes up training data in ways that could cause serious damage to image-generating AI models.
Everything you need to know about artificial wombs
Artificial wombs are nearing human trials. But the goal is to save the littlest preemies, not replace the uterus.
Rogue superintelligence and merging with machines: Inside the mind of OpenAI’s chief scientist
An exclusive conversation with Ilya Sutskever on his fears for the future of AI and why they’ve made him change the focus of his life’s work.
Data analytics reveal real business value
Sophisticated analytics tools mine insights from data, optimizing operational processes across the enterprise.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.